Table 2.
Clinicopathological characteristics according to ALK rearrangement status
| ALK positive | ALK negative | P value | |
|---|---|---|---|
| N |
6 |
211 |
|
| Age |
60.00 ± 12.05 |
63.22 ± 10.13 |
0.579 |
| Sex (M:F) |
2:4 |
96:115 |
0.692 |
| PYR |
0.750 ± 1.173 |
9.769 ± 17.381 |
0.464 |
| Pathologic stage |
6 |
206* |
0.018 |
| 0 |
0 |
15 |
|
| IA |
1 |
143 |
|
| IB |
3 |
33 |
|
| IIA |
1 |
5 |
|
| IIB |
0 |
2 |
|
| IIIA |
1 |
7 |
|
| IIIB |
0 |
1 |
|
| Nodal involvement |
2 |
13 |
0.060 |
| Histologic invasiveness |
6 |
210† |
0.554 |
| AIS |
0 |
15 |
|
| MIA |
0 |
16 |
|
| IA |
6 |
179 |
|
| Maximal diameter |
33.583 ± 13.736 |
22.528 ± 10.690 |
0.037 |
| Solid diameter |
23.217 ± 16.906 |
11.452 ± 10.920 |
0.039 |
| TDR | 0.533 ± 0.327 | 0.700 ± 0.290 | 0.209 |
*Data for pathologic stage were unavailable for 5 patients.
†Data for histologic invasiveness were unavailable for 1 patient.